Omega Healthcare Investors INC Form 4 insider transactions

NYSE
Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors, Inc., acquired OP Units through the vesting of Profits Interest Units.
NYSE
C. Taylor Pickett, CEO of Omega Healthcare Investors, acquired OP Units following the vesting of Profits Interest Units on September 30, 2024.
NYSE
Daniel J. Booth, Chief Operating Officer of Omega Healthcare Investors, Inc., sold 25,000 shares of common stock at an average price of $40.06 on September 5, 2024.
NYSE
Robert O. Stephenson, CFO of Omega Healthcare Investors, Inc., sold 30,000 shares of common stock on August 26, 2024, at a weighted average price of $38.784 per share.
NYSE
Daniel J. Booth, Chief Operating Officer of Omega Healthcare Investors, Inc., sold 25,000 shares of common stock at a weighted average price of $38.7072 on August 23, 2024.
NYSE
Director Lisa Egbuonu-Davis sold 1,352 shares of Omega Healthcare Investors Inc. on August 13, 2024, at a price of $38 per share.
NYSE
Robert O. Stephenson, CFO of Omega Healthcare Investors, Inc., acquired OP Units following the vesting of Profits Interest Units on June 30, 2024.
NYSE
CEO C. Taylor Pickett acquired OP Units in Omega Healthcare Investors following the vesting of Profits Interest Units, as reported in a Form 4 filing.
NYSE
Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors, reports the vesting of Profits Interest Units into OP Units and subsequent ownership of common stock.
NYSE
Daniel J. Booth, Chief Operating Officer of Omega Healthcare Investors, reports the vesting of Profits Interest Units into OP Units and subsequent ownership of common stock.
NYSE
Neal Ballew, Chief Accounting Officer of Omega Healthcare Investors, reports stock purchases through the Employee Stock Purchase Plan, sales to cover tax obligations, and the vesting of Profits Interest Units into OP Units.
NYSE
Robert O. Stephenson, CFO of Omega Healthcare Investors, disposed of 1,850 shares of common stock on June 21, 2024, as reported in a Form 4 filing with the SEC.
NYSE
Director Barbara Hill reports the acquisition and conversion of Profits Interest Units (PIUs) into OP Units and common stock of Omega Healthcare Investors.
NYSE
Director Burke W. Whitman acquired 4,605 shares of Omega Healthcare Investors, Inc. common stock as part of director compensation.
NYSE
Director Stephen D. Plavin reports the acquisition and conversion of Profits Interest Units (PIUs) into OP Units and common stock of Omega Healthcare Investors.
NYSE
Director Kevin J. Jacobs acquired 7,522 shares of Omega Healthcare Investors, Inc. as part of director compensation.
NYSE
Lisa Egbuonu-Davis, a director at Omega Healthcare Investors, acquired 4,605 shares of common stock as part of her director compensation, vesting approximately one year from the grant date.
NYSE
Director Craig R. Callen of Omega Healthcare Investors Inc. reports the acquisition and conversion of Profits Interest Units (PIUs) into OP Units and common stock.
NYSE
Director Anand Kapila K acquired 5,756 deferred stock units in Omega Healthcare Investors, Inc., convertible to common stock, as part of an annual grant.
NYSE
Omega Healthcare Investors Inc. officer Neal Ballew reports acquisition of shares through the Employee Stock Purchase Plan and subsequent sale to cover tax obligations, along with the vesting of Profits Interest Units into OP Units.
NYSE
Gail D. Makode, Chief Legal Officer of Omega Healthcare Investors, reports the acquisition of OP Units following the vesting of Profits Interest Units.
NYSE
Robert O. Stephenson, CFO of Omega Healthcare Investors, acquired 20,286 OP Units following the vesting of Profits Interest Units on March 31, 2024.
NYSE
Daniel J. Booth, Chief Operating Officer of Omega Healthcare Investors, Inc., acquired OP Units following the vesting of Profits Interest Units on March 31, 2024.
NYSE
Omega Healthcare Investors CEO, C. Taylor Pickett, acquired 47,655 OP Units through the vesting of Profits Interest Units on March 31, 2024.